Abstract

Scarce evidence is available in Asia for estimating the long-term risk and prognostic factors of major complications such as re-rupture, vasospasm, or re-stroke for patients with aneurysmal subarachnoid hemorrhage (SAH) undergoing endovascular coil embolization or surgical clipping. This is the first head-to-head propensity score-matched study in an Asian population to demonstrate that endovascular coil embolization for aneurysmal SAH treatment is riskier than surgical clipping in terms of re-rupture, vasospasm, or re-stroke. In addition, the independent poor prognostic factors of vasospasm or re-stroke were endovascular coil embolization, male sex, older age (≥65 years; the risk of vasospasm increases with age), hypertension, congestive heart failure, diabetes, previous transient ischemic attack, or stroke in aneurysmal SAH treatment. Background: To estimate the long-term complications and prognostic factors of endovascular coil embolization or surgical clipping for patients with ruptured aneurysmal subarachnoid hemorrhage (SAH). Methods: We selected patients diagnosed with aneurysmal SAH between 1 January 2011 and 31 December 2017. Propensity score matching was performed, and Cox proportional hazards model curves were used to analyze the risk of re-rupture, vasospasm, and re-stroke in patients undergoing the different treatments. Findings: Multivariate Cox regression analysis revealed that the adjusted hazard ratio (aHR) of re-rupture for endovascular coil embolization compared with surgical clipping was 1.36 (95% confidence interval [CI]: 1.17–1.57; p < 0.0001). The aHRs of the secondary endpoints of vasospasm and re-stroke (delayed cerebral ischemia) for endovascular coil embolization compared with surgical clipping were 1.14 (1.02–1.27; p = 0.0214) and 2.04 (1.83–2.29; p < 0.0001), respectively. The independent poor prognostic factors for vasospasm and re-stroke were endovascular coil embolization, male sex, older age (≥65 years; risk increases with age), hypertension, congestive heart failure, diabetes, and previous transient ischemic attack or stroke. Interpretation: Endovascular coil embolization for aneurysmal SAH carries a higher risk than surgical clipping of both short- and long-term complications including re-rupture, vasospasm, and re-stroke.

Highlights

  • Aneurysmal subarachnoid hemorrhage (SAH) is a life-threatening event

  • After applying inclusion and exclusion criteria and propensity score matching (PSM), 8102 patients (4051 each in the endovascular coil embolization and surgical clipping groups) were considered for analysis; their characteristics are summarized in Supplemental Table S1

  • Sex, year of diagnosis, aneurysm locations, diabetes, congestive heart failure, hypertension, renal diseases, stroke or transient ischemic attack (TIA), Charlson comorbidity index (CCI) score, hospital level, hospital area, and income were similar in the two cohorts (Supplemental Table S1)

Read more

Summary

Introduction

The primary aim of aneurysmal SAH management is the prevention of re-rupture (re-bleeding) by early repair with surgical clipping or endovascular coiling [1,2,3]. After aneurysmal SAH, the patient is at substantial risk of early re-rupture (4%–14% in the first 24 h, with maximal risk in the first 2–12 h) [2,5,6,7,8]. Aneurysm repair with surgical clipping or endovascular coiling is the only effective treatment to prevent re-rupture [2], but some risk of re-rupture remains even after repair [2,5,6,7,8,9,10,11,12]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call